A detailed history of Mariner, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Mariner, LLC holds 7,032 shares of GKOS stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,032
Previous 6,773 3.82%
Holding current value
$1.01 Million
Previous $801,000 14.36%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$113.62 - $135.39 $29,427 - $35,066
259 Added 3.82%
7,032 $916,000
Q2 2024

Aug 13, 2024

BUY
$89.48 - $118.35 $30,423 - $40,239
340 Added 5.29%
6,773 $801,000
Q1 2024

May 15, 2024

BUY
$76.4 - $96.33 $7,792 - $9,825
102 Added 1.61%
6,433 $606,000
Q4 2023

Feb 14, 2024

BUY
$59.53 - $85.11 $6,726 - $9,617
113 Added 1.82%
6,331 $503,000
Q3 2023

Nov 13, 2023

BUY
$69.23 - $79.09 $28,453 - $32,505
411 Added 7.08%
6,218 $467,000
Q2 2023

Aug 11, 2023

BUY
$45.44 - $71.21 $8,315 - $13,031
183 Added 3.25%
5,807 $413,000
Q1 2023

May 12, 2023

SELL
$43.88 - $52.48 $965 - $1,154
-22 Reduced 0.39%
5,624 $282,000
Q4 2022

Feb 14, 2023

SELL
$40.82 - $57.75 $15,185 - $21,483
-372 Reduced 6.18%
5,646 $247,000
Q3 2022

Nov 10, 2022

BUY
$46.84 - $58.49 $281,883 - $351,992
6,018 New
6,018 $320,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.86B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.